Author: Limited A.I.
Publisher: Adis International
ISSN: 1174-5886
Source: Drugs in R&D, Vol.4, Iss.4, 2003-01, pp. : 243-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Whitehead Robert McCoy Sheryl Macdonald John Rivkin Saul Neubauer Marcus Dakhil Shaker Lenz Heinz-Josef Tanaka Michael Abbruzzese James
Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. :
Erlotinib dominates docetaxel for NSCLC
Inpharma, Vol. 1, Iss. 1612, 2007-01 ,pp. :
Drugs & Therapy Perspectives, Vol. 22, Iss. 4, 2006-04 ,pp. :
Erlotinib improves QOL in NSCLC
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. :
Erlotinib worth it in Mexico . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. :